MAR 03, 2016 10:18 AM PST

Blood Test Predicts Risks for Recurrent Strokes

WRITTEN BY: Xuan Pham
Increased levels of a blood protein may make a person not only more susceptible to strokes, but could also send the person right back in the hospital with a second brain stroke. In a new study, researchers found a way to leverage knowledge about this protein in a blood test that could inform doctors and patients the risks of recurrent strokes. The results were published in Neurology journal. 
 
 
Image credit: Pixabay.com
 
Strokes, also known as cerebrovascular accidents or brain attacks, occur when cells in the brain die due to insufficient blood flow (ischemia) or bleeding within the brain tissue (hemorrhagic). Every year, nearly 800,000 people in the United States suffer a stroke, and of that over 80% are in the ischemic type. Strokes kill about 130,000 Americans every year.

"The biggest risk of death for someone who has already had a stroke is to have another one," said University of Virginia School of Medicine researcher Stephen Williams, PhD. "So it's really important to be able to try and target those individuals who are at the highest risk for the thing that very well may kill them."

As with many health conditions, genetics play a big role in risk for strokes. Researchers at the University of Virginia found that high levels of a blood-based biomarker, C-Reactive Protein (CRP), actually influences this risk and the risk for recurrent strokes.

CRP is an inflammatory protein made in the liver, and has been linked to other health conditions like coronary artery disease. High levels of CRP cause arterial plaques to be unstable and break off, causing blockages like that in ischemic strokes.

The UVA researchers also found that certain genetic variants are involved in CRP levels and stroke risks. "There's this shared genetic susceptibility not only for increased C-Reactive Protein but for increased risk for stroke. We could estimate what's called a hazard ratio - basically the increased risk for having or not having a second stroke - based on the genetics,” said Williams.

A blood draw, then, could let doctors know the CRP levels as well as the person’s genetic profile related to stroke predisposition. This information could allow doctors to monitor high-risk patients and intervene early enough to treat, and possibly even prevent, second strokes. Best of all, researchers say the tool for applying this diagnostic test is already in place.

 "Getting a CRP measure on someone is really simple. It's just a blood draw. You don't have to take something like a biopsy which patients might have an aversion to," Williams said. "It's not very expensive, and it's part of routine workups that could be done for patients. However, combined with genetic information, we may have even more power to identify those at greatest risk."

Additional source: MNT
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 05, 2019
Clinical & Molecular DX
NOV 05, 2019
Meningitis and Encephalitis: Testing & Diagnosis Strategies for Effective Treatment
Meningitis is an inflammation of the membranes surrounding the brain (meninges) and spinal cord. Encephalitis, on the other hand, refers to inflammation of...
DEC 11, 2019
Clinical & Molecular DX
DEC 11, 2019
New 3-in-1 organ in a dish set to elevate research and diagnostics
In trying to understand complex phenomena in the human body, researchers usually have to turn to oversimplified biological models. Amongst the easiest to u...
DEC 17, 2019
Immunology
DEC 17, 2019
Increased Belly Fat with Aging Linked to Reduced Mental Flexibility
Did you ever consider that your brain can flex similarly to the way your biceps can? Sure, brain flexing is more abstract and less literal, but the concept...
JAN 21, 2020
Clinical & Molecular DX
JAN 21, 2020
Brain scans of teens predict their risk of binge drinking
We’ve seen teenage binge drinking widely represented in popular culture. There is, however, a dark side to what many consider harmless fun. Mounting...
JAN 28, 2020
Clinical & Molecular DX
JAN 28, 2020
Protein complex discovered as first biomarker of PTSD
  Researchers at the Centre for Addiction and Mental Health (CAMH) and the Canadian Institutes of Health Research (CIHR) have identified a potential d...
APR 01, 2020
Clinical & Molecular DX
APR 01, 2020
One dollar kit diagnoses COVID-19 in 10 minutes
Researchers have begun efficacy testing for a new SARS-CoV-2 diagnostic kit that claims to be able to test for COVID-19 infection in just 10 minutes. In th...
Loading Comments...